1. Home
  2. ABOS vs OPAL Comparison

ABOS vs OPAL Comparison

Compare ABOS & OPAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABOS
  • OPAL
  • Stock Information
  • Founded
  • ABOS 1996
  • OPAL 1998
  • Country
  • ABOS United States
  • OPAL United States
  • Employees
  • ABOS N/A
  • OPAL N/A
  • Industry
  • ABOS Biotechnology: Pharmaceutical Preparations
  • OPAL Natural Gas Distribution
  • Sector
  • ABOS Health Care
  • OPAL Utilities
  • Exchange
  • ABOS Nasdaq
  • OPAL Nasdaq
  • Market Cap
  • ABOS 99.1M
  • OPAL 109.4M
  • IPO Year
  • ABOS 2021
  • OPAL N/A
  • Fundamental
  • Price
  • ABOS $1.65
  • OPAL $3.15
  • Analyst Decision
  • ABOS Strong Buy
  • OPAL Buy
  • Analyst Count
  • ABOS 3
  • OPAL 6
  • Target Price
  • ABOS $9.33
  • OPAL $7.90
  • AVG Volume (30 Days)
  • ABOS 412.7K
  • OPAL 138.1K
  • Earning Date
  • ABOS 11-12-2024
  • OPAL 03-12-2025
  • Dividend Yield
  • ABOS N/A
  • OPAL N/A
  • EPS Growth
  • ABOS N/A
  • OPAL N/A
  • EPS
  • ABOS N/A
  • OPAL 0.18
  • Revenue
  • ABOS N/A
  • OPAL $306,957,000.00
  • Revenue This Year
  • ABOS N/A
  • OPAL $24.97
  • Revenue Next Year
  • ABOS N/A
  • OPAL $32.05
  • P/E Ratio
  • ABOS N/A
  • OPAL $17.87
  • Revenue Growth
  • ABOS N/A
  • OPAL 30.17
  • 52 Week Low
  • ABOS $1.53
  • OPAL $2.96
  • 52 Week High
  • ABOS $5.09
  • OPAL $5.18
  • Technical
  • Relative Strength Index (RSI)
  • ABOS 39.18
  • OPAL 37.59
  • Support Level
  • ABOS $1.54
  • OPAL $3.24
  • Resistance Level
  • ABOS $1.75
  • OPAL $3.32
  • Average True Range (ATR)
  • ABOS 0.13
  • OPAL 0.14
  • MACD
  • ABOS 0.01
  • OPAL -0.00
  • Stochastic Oscillator
  • ABOS 28.57
  • OPAL 4.88

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

Share on Social Networks: